FDA Adverse Event Injury Summary report: N

SYMBIQ DUAL CHANNEL

MDR report key: 2080631 · Received April 25, 2011

Report

Report Number
9615050-2011-00291
Event Type
Injury
Date Received
April 25, 2011
Date of Event
March 30, 2011
Report Date
April 14, 2011
Manufacturer
HOSPIRA COSTA RICA LTD.
Product Code
FRN
PMA / PMN Number
K041550
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE IS EXPECTED TO BE RETURNED FOR INVESTIGATION. IT HAS NOT YET BEEN RECEIVED. THIS REPORT REPRESENTS ALL THE INFO KNOWN BY THE REPORTER UPON QUERY BY HOSPIRA PERSONNEL. (B)(4).

Description of Event or Problem · 1

THE CUSTOMER CONTACT REPORTED A DELAY OF CRITICAL THERAPY FOLLOWING AN ALARM CONDITION. AT AN UNSPECIFIED TIME, THE DEVICE WAS PROGRAMMED TO DELIVER AN UNSPECIFIED CONCENTRATION OF LEVOPHED, AT A RATE OF 13MCG/MIN AND THE DELIVERY WAS STATED. NO FURTHER PROGRAMMING PARAMETERS WERE PROVIDED. AT 1500, THE NURSE NOTED THE DELIVERY HAD STOPPED. AT THIS TIME, THE DISPLAY OF THE DEVICE WAS WHITE AND THE TOUCHSCREEN DID NOT RESPOND. IT WAS UNSPECIFIED IF THERE WAS AN AUDIBLE ALARM TONE. AT THAT TIME, THE NURSE REPORTED A DECREASE IN THE PT'S BLOOD PRESSURE TO 60/30MHG. THE DEVICE WAS REMOVED FROM CLINICAL SERVICE. THE PHYSICIAN WAS NOTIFIED. AT THIS TIME, THE PT WAS TREATED WITH PHENYLEPHRINE 100MG IVP. A SECOND 100MG DOSE OF PHENYLEPHRINE WAS GIVEN 10 MINUTES LATER. A REPLACEMENT DEVICE WAS PROGRAMMED TO DELIVER LEVOPHED 16MCG/MIN AND THE THERAPY WAS REUSED. IT WAS REPORTED THAT FOR THE NEXT 1.5 HOURS, THE DELIVERY RATE WAS TITRATED TO 13MCG/MIN TO MAINTAIN A MEAN BLOOD PRESSURE OF 60MMHG. AFTER AN UNSPECIFIED LENGTH OF TIME, THE CUSTOMER CONTACT REPORTED THE PT WAS "STABLE." THOUGH REQUESTED, NO ADD'L INFO WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SYMBIQ DUAL CHANNEL 80FRN FRN HOSPIRA COSTA RICA LTD. NA NA

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention LEVOPHED: MFR UNK